DK1429843T3 - Kombination af en PDE-inhibitor og et leukotrien-receptorantagonist - Google Patents

Kombination af en PDE-inhibitor og et leukotrien-receptorantagonist

Info

Publication number
DK1429843T3
DK1429843T3 DK02798730T DK02798730T DK1429843T3 DK 1429843 T3 DK1429843 T3 DK 1429843T3 DK 02798730 T DK02798730 T DK 02798730T DK 02798730 T DK02798730 T DK 02798730T DK 1429843 T3 DK1429843 T3 DK 1429843T3
Authority
DK
Denmark
Prior art keywords
combination
leukotriene receptor
receptor antagonist
pde inhibitor
leukotriene
Prior art date
Application number
DK02798730T
Other languages
Danish (da)
English (en)
Inventor
Rolf Beume
Stefan-Lutz Wollin
Christian Weimar
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1429843T3 publication Critical patent/DK1429843T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02798730T 2001-09-19 2002-09-17 Kombination af en PDE-inhibitor og et leukotrien-receptorantagonist DK1429843T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01000474 2001-09-19
PCT/EP2002/010423 WO2003024488A2 (en) 2001-09-19 2002-09-17 Combination of a pde inhibitor and a leukotriene receptor antagonist

Publications (1)

Publication Number Publication Date
DK1429843T3 true DK1429843T3 (da) 2007-04-30

Family

ID=8176066

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02798730T DK1429843T3 (da) 2001-09-19 2002-09-17 Kombination af en PDE-inhibitor og et leukotrien-receptorantagonist

Country Status (25)

Country Link
US (1) US20050014762A1 (de)
EP (1) EP1429843B1 (de)
JP (1) JP2005505570A (de)
KR (1) KR20040044946A (de)
CN (1) CN100346831C (de)
AT (1) ATE349243T1 (de)
BR (1) BR0212582A (de)
CA (1) CA2460442A1 (de)
CO (1) CO5560584A2 (de)
CY (1) CY1106365T1 (de)
DE (1) DE60217139T2 (de)
DK (1) DK1429843T3 (de)
EA (1) EA007736B1 (de)
ES (1) ES2279004T3 (de)
HU (1) HUP0500078A3 (de)
IL (2) IL160272A0 (de)
MA (1) MA27136A1 (de)
MX (1) MXPA04002560A (de)
NO (1) NO331885B1 (de)
NZ (1) NZ532279A (de)
PL (1) PL205927B1 (de)
PT (1) PT1429843E (de)
SI (1) SI1429843T1 (de)
WO (1) WO2003024488A2 (de)
ZA (1) ZA200402653B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy
US20100210611A1 (en) * 2007-10-25 2010-08-19 Roch Thibert Combination therapy
WO2012168907A1 (en) 2011-06-10 2012-12-13 Glenmark Pharmaceuticals Sa Pharmaceutical composition comprising revamilast and montelukast or zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
CN105121439A (zh) 2013-02-19 2015-12-02 辉瑞公司 作为pde4亚型抑制剂用于治疗cns和其他病症的氮杂苯并咪唑化合物
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US20160339010A1 (en) 2014-01-22 2016-11-24 Takeda Gmbh Treatment of Partly Controlled or Uncontrolled Severe Asthma
WO2016012896A1 (en) 2014-07-24 2016-01-28 Pfizer Inc. Pyrazolopyrimidine compounds
PL3177624T3 (pl) 2014-08-06 2019-09-30 Pfizer Inc. Związki imidazopirydazynowe

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY121142A (en) * 1999-02-23 2005-12-30 Smithkline Beecham Corp Controlled release formulation for treating copd
EP1212089B1 (de) * 1999-08-21 2006-03-22 ALTANA Pharma AG Synergistische kombination von roflumilast und salmeterol
MY134008A (en) * 1999-12-22 2007-11-30 Merck Frosst Canada Inc Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
EP1252158B1 (de) * 2000-01-31 2005-04-20 Pfizer Products Inc. Nicotinamide benzoanellierte-heterocyclische derivate als selektive inhibitoren der pde4 isoenzyme
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
AU2001261962B2 (en) * 2000-05-25 2005-04-21 Merck Frosst Canada Ltd Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor

Also Published As

Publication number Publication date
IL160272A0 (en) 2004-07-25
CN1655846A (zh) 2005-08-17
BR0212582A (pt) 2004-10-13
MXPA04002560A (es) 2004-05-31
ZA200402653B (en) 2005-02-14
SI1429843T1 (sl) 2007-06-30
HUP0500078A2 (hu) 2005-04-28
PT1429843E (pt) 2007-03-30
EA200400416A1 (ru) 2004-12-30
NO331885B1 (no) 2012-04-30
EP1429843A2 (de) 2004-06-23
CN100346831C (zh) 2007-11-07
NO20041595L (no) 2004-06-16
NZ532279A (en) 2006-02-24
PL205927B1 (pl) 2010-06-30
WO2003024488A2 (en) 2003-03-27
EA007736B1 (ru) 2006-12-29
CO5560584A2 (es) 2005-09-30
KR20040044946A (ko) 2004-05-31
PL367414A1 (en) 2005-02-21
ES2279004T3 (es) 2007-08-16
JP2005505570A (ja) 2005-02-24
MA27136A1 (fr) 2005-01-03
HUP0500078A3 (en) 2010-07-28
DE60217139T2 (de) 2007-10-04
WO2003024488A3 (en) 2003-09-04
HK1066752A1 (en) 2005-04-01
IL160272A (en) 2008-03-20
ATE349243T1 (de) 2007-01-15
DE60217139D1 (de) 2007-02-08
CA2460442A1 (en) 2003-03-27
CY1106365T1 (el) 2011-10-12
US20050014762A1 (en) 2005-01-20
EP1429843B1 (de) 2006-12-27

Similar Documents

Publication Publication Date Title
CY1106365T1 (el) Συνδυασμος ενος αναστολεα pde και ενος ανταγωνιστη υποδοχεων λευκοτριενιου
CY1106927T1 (el) Φαρμακευτικη συνθεση ενος pde4 ή pde3/4 αναστολεα και ανταγωνιστη υποδοχεα ισταμινης
NO20045434L (no) En kombinasjon av en NMDA-antagonist og acetylkolinesteraseinhibitorer for behandlingen av Alzheimers sykdom
EP1370211A4 (de) Gleichzeitige verabreichung eines melanocortin rezeptor-agonists und eines phosphodiesterase-hemmers zur behandlung von erkrankungen im zusammenhang mit zyklischer amp
DK1297825T3 (da) Faste orale dosisformer af simethicon
UA94390C2 (ru) Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких
CY2008008I1 (el) Ν-υποκατεστημενοι υδροξυπυριμιδινονο-καρβοξαμιδικοι ανσατολεις της ιντεγρασης hiv
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
NO20034311D0 (no) CCR5-antagonister for behandling av AIDS
UY26851A1 (es) Derivados de la 4-fenilpiridina
NO20033417D0 (no) Anvendelse av CD23-antagonister for behandling av neoplastiske forstyrrelser
WO2002081728A3 (en) Quinoline inhibitors of hyak1 and hyak3 kinases
NO20023448L (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
ID29818A (id) Penggunaan antagonis reseptor angiotensin ii untuk mengobati infarksi miokardial
HUP0401858A3 (en) Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
NO20033634L (no) GLyT-1-inhibitorer